TrueBinding Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 75

Employees

  • Latest Deal Type
  • Series D1

  • Latest Deal Amount
  • $57.7M

  • Investors
  • 1

TrueBinding General Information

Description

Developer of antibody drugs designed for applications in immune oncology and other disease areas. The company's drugs offer novel ligands to receptors of known checkpoint inhibitor pathways and an artificial intelligence and big data technology-powered platform, providing patients with anti-cancer immunotherapy and targetted anti-body drug delivery.

Contact Information

Formerly Known As
Immutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 Lincoln Centre Drive
  • Suite 200
  • Foster City, CA 94404
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 300 Lincoln Centre Drive
  • Suite 200
  • Foster City, CA 94404
  • United States
+1 (650)

TrueBinding Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TrueBinding Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D1) 20-Jun-2023 $57.7M Completed Clinical Trials - Phase 2
3. Later Stage VC (Series D) 03-Nov-2022 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series C) 16-Jun-2022 $100M $150M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series B) 13-Jul-2020 $49.7M $49.7M Completed Clinical Trials - Phase 2
To view TrueBinding’s complete valuation and funding history, request access »

TrueBinding Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 30,000,000 $0.000010 $0.1 $0.1 1x $0.1 22.68%
To view TrueBinding’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TrueBinding Patents

TrueBinding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240352131-A1 Methods of treating eye disease Pending 18-Apr-2023
US-20230279120-A1 Methods of treating or inhibiting cardiovascular diseases Pending 09-Nov-2021
AU-2022388722-A1 Methods of treating or inhibiting cardiovascular diseases Pending 09-Nov-2021
CA-3238590-A1 Methods of treating or inhibiting cardiovascular diseases Pending 09-Nov-2021
EP-4429701-A1 Methods of treating or inhibiting cardiovascular diseases Pending 09-Nov-2021 C07K16/2851
To view TrueBinding’s complete patent history, request access »

TrueBinding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TrueBinding Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
ShangBay Capital Venture Capital Minority
To view TrueBinding’s complete investors history, request access »

TrueBinding FAQs

  • When was TrueBinding founded?

    TrueBinding was founded in 2016.

  • Where is TrueBinding headquartered?

    TrueBinding is headquartered in Foster City, CA.

  • What is the size of TrueBinding?

    TrueBinding has 75 total employees.

  • What industry is TrueBinding in?

    TrueBinding’s primary industry is Drug Discovery.

  • Is TrueBinding a private or public company?

    TrueBinding is a Private company.

  • What is TrueBinding’s current revenue?

    The current revenue for TrueBinding is .

  • How much funding has TrueBinding raised over time?

    TrueBinding has raised $228M.

  • Who are TrueBinding’s investors?

    ShangBay Capital has invested in TrueBinding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »